Evidence map›Paper›PMID 25786853›Full record

ArticleGenetics2015

Interplay between histone H3 lysine 56 deacetylation and chromatin modifiers in response to DNA damage.

Antoine Simoneau, Neda Delgoshaie, Ivana Celic, Junbiao Dai, Nebiyu Abshiru, Santiago Costantino, Pierre Thibault, Jef D Boeke, Alain Verreault, Hugo Wurtele

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Chromatin architecture sets origin licensing capacity.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Effects of sirtuins on the riboflavin production in Ashbya gossypii.Applied microbiology and biotechnology · 2021
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Antoine SimoneauCentre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada H1T 2M4.
Neda DelgoshaieInstitute for Research in Immunology and Cancer, Université de Montréal, Succursale Centre-Ville, Montreal, QC, Canada H3C 3J7.
Ivana CelicHigh Throughput Biology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
Junbiao DaiHigh Throughput Biology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 School of Life Sciences, Tsinghua University, Beijing, China 100084.
Nebiyu AbshiruInstitute for Research in Immunology and Cancer, Université de Montréal, Succursale Centre-Ville, Montreal, QC, Canada H3C 3J7 Département de Chimie, Université de Montréal, Succursale Centre-Ville, Montreal, QC, Canada H3C 3J7.
Santiago CostantinoCentre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada H1T 2M4 Département d'ophtalmologie, Université de Montréal, Succursale Centre-Ville, Montreal, QC, Canada H3C 3J7.
Pierre ThibaultInstitute for Research in Immunology and Cancer, Université de Montréal, Succursale Centre-Ville, Montreal, QC, Canada H3C 3J7 Département de Chimie, Université de Montréal, Succursale Centre-Ville, Montreal, QC, Canada H3C 3J7.
Jef D BoekeHigh Throughput Biology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 Institute for Systems Genetics and Department of Biochemistry and Molecular Pharmacology, New York University Langone Medical Center, New York, New York 10016.
Alain VerreaultInstitute for Research in Immunology and Cancer, Université de Montréal, Succursale Centre-Ville, Montreal, QC, Canada H3C 3J7 Département de Pathologie et Biologie Cellulaire, Université de Montréal, Succursale Centre-Ville, Montreal, QC, Canada H3C 3J7.
Hugo WurteleCentre de recherche de l'Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada H1T 2M4 Département de Médecine, Université de Montréal, Succursale Centre-Ville, Montreal, QC, Canada H3C 3J7 hugo.wurtele@umontreal.ca.
Hôpital Maisonneuve-Rosemont · CAUniversité de Montréal · CAHigh Throughput Biology (United States) · USInstitute for Research in Immunology and Cancer · CATsinghua University · CN

Funding

Networks, Pathways and Dynamics of Lysine ModificationU54GM103520 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI BADER, JOEL S. · 2012 to 2013
$7.0M
Canadian Institutes of Health Research IC1-123780Canadian Institutes of Health Research MOP 123438Canadian Institutes of Health Research MOP 89928NIGMS NIH HHS U54 GM-103520NIGMS NIH HHS U54 GM103520
6 · The paper itself

Abstract

In Saccharomyces cerevisiae, histone H3 lysine 56 acetylation (H3K56Ac) is present in newly synthesized histones deposited throughout the genome during DNA replication. The sirtuins Hst3 and Hst4 deacetylate H3K56 after S phase, and virtually all histone H3 molecules are K56 acetylated throughout the cell cycle in hst3∆ hst4∆ mutants. Failure to deacetylate H3K56 causes thermosensitivity, spontaneous DNA damage, and sensitivity to replicative stress via molecular mechanisms that remain unclear. Here we demonstrate that unlike wild-type cells, hst3∆ hst4∆ cells are unable to complete genome duplication and accumulate persistent foci containing the homologous recombination protein Rad52 after exposure to genotoxic drugs during S phase. In response to replicative stress, cells lacking Hst3 and Hst4 also displayed intense foci containing the Rfa1 subunit of the single-stranded DNA binding protein complex RPA, as well as persistent activation of DNA damage-induced kinases. To investigate the basis of these phenotypes, we identified histone point mutations that modulate the temperature and genotoxic drug sensitivity of hst3∆ hst4∆ cells. We found that reducing the levels of histone H4 lysine 16 acetylation or H3 lysine 79 methylation partially suppresses these sensitivities and reduces spontaneous and genotoxin-induced activation of the DNA damage-response kinase Rad53 in hst3∆ hst4∆ cells. Our data further suggest that elevated DNA damage-induced signaling significantly contributes to the phenotypes of hst3∆ hst4∆ cells. Overall, these results outline a novel interplay between H3K56Ac, H3K79 methylation, and H4K16 acetylation in the cellular response to DNA damage.

Indexed as

DNA DamageProtein Processing, Post-TranslationalAcetylationCell Cycle ProteinsCheckpoint Kinase 2ChromatinHistone DeacetylasesHistonesMethylationRad52 DNA Repair and Recombination ProteinReplication Protein ASaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsCell Cycle ProteinsCheckpoint Kinase 2ChromatinHistone DeacetylasesHistonesHst3 protein, S cerevisiaeHst4 protein, S cerevisiaeRad52 DNA Repair and Recombination ProteinRAD52 protein, S cerevisiaeRAD53 protein, S cerevisiaeReplication Protein ARFA1 protein, S cerevisiaeSaccharomyces cerevisiae Proteinschromatin structureDNA damage repair and checkpoint responseH3 lysine 56 acetylationH3 lysine 79 methylationH4 lysine 16 acetylation

Identifiers

PMID25786853
PMCPMC4423362
OpenAlexW2024619620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.